Arcapita exits healthcare investment

Arcapita and Mumtalakat consortium exits stake in NAS Neuron Health Services

  
Atif Abdulmalik, CEO, Arcapita Group

Atif Abdulmalik, CEO, Arcapita Group

  • The successful investment has exceeded target returns over a three-year holding period

Manama – Arcapita Group Holdings (“Arcapita”), the global alternative investments firm, and Bahrain Mumtalakat Holding Company (“Mumtalakat”), the sovereign wealth fund of the Kingdom of Bahrain, announced today the sale of their stake in NAS Neuron Health Services L.L.C. (“NAS Neuron”), a leading provider of outsourced medical claims processing services in the GCC, to a leading US based Fortune 500 company. The successful investment has exceeded target returns over a three-year holding period.

In 2017, Arcapita and Mumtalakat partnered to acquire an equity stake in NAS United Healthcare Services LLC. Over the past three years, the consortium supported the company’s execution of a series of organic and inorganic growth initiatives, including the business combination with another major UAE third-party administrator (TPA), Neuron LLC, the implementation of a variety of strategic initiatives to drive customer growth and reduce costs, and the roll-out of healthcare technology services among its clients.

Today NAS Neuron is one of the largest private TPAs of medical claims in the GCC, serving over 1.3 million lives across the GCC region.

Atif A. Abdulmalik, Arcapita’s Chief Executive Officer, commented, “We are pleased to have achieved this exit in the current economic environment. The UAE and GCC’s private health insurance market has been undergoing a major transformation over the past few years as governments have sought to shift healthcare expenditures from the public to the private sector. NAS Neuron has been a beneficiary of this trend and the company has successfully navigated the TPA market by rebalancing its portfolio mix, maintaining a strong technology backbone, and improving operating efficiency.”

He added: “Healthcare and wellness are among Arcapita’s focus areas for both our private equity and real estate platforms given the demographic tailwinds supporting this sector. We plan to continue focusing on defensive sectors that are supported by long-term market fundamentals. In addition, the success of our investment in NAS Neuron highlights the resilience of the UAE and GCC private equity market as well as the attractiveness of the region’s healthcare sector to global investors despite a challenging economic environment.”

HE Khalid Al Rumaihi, Chief Executive Officer of Mumtalakat said, “Our strategic partnership with Arcapita enabled us to support and witness NAS Neuron’s progress into one of the leading players in the GCC health sector with a solid management structure, and a clear vision to continue on its growth trajectory. The successful culmination and positive outcome of this venture is a validation of the robust and sound nature of our collective business strategy, and is in line with our efforts towards maintaining a diverse and sustainable portfolio.”

Umair Nizami, Group Chief Executive Officer of NAS Neuron, commented, "Backed by strong strategic shareholders, including Arcapita and Mumtalakat, we successfully brought together the strengths of NAS and Neuron to benefit the wider healthcare industry. I am personally grateful for the trust placed in me by the shareholders, and I look forward to continuing to enhance our value proposition so that our customers enjoy easy access to high quality and affordable healthcare across the globe."

- Ends -

For further information, please contact:
Arcapita
Tariq Hayat
Tel: +973 17 218 858
Email: thayat@arcapita.com

Finsbury
John Hobday
Email: John.hobday@finsbury.com 

About Arcapita

Arcapita is a global alternative investment manager, with offices in Atlanta, London and Singapore and an affiliated office in Bahrain. Arcapita’s principal lines of business are private equity and real estate, and its management has a 20-year track record of over 90 investments with total transaction value in excess of $30 billion.

Further details on Arcapita can be found at www.arcapita.com 

About Mumtalakat

Mumtalakat, the Bahrain Mumtalakat Holding Company, is the sovereign wealth fund of the Kingdom of Bahrain. With a mandate to grow the wealth of Bahrain through long-term investments based on sound financial, strategic and governance principles, Mumtalakat holds stakes in over 60 commercial enterprises with a portfolio spanning a variety of sectors, including industrial manufacturing, financial services, telecommunications, real estate, logistics, consumer products, healthcare and education.

Further details on Mumtalakat can be found at www.mumtalakat.bh 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases